查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528048

電療/生物電醫學全球市場

Electroceuticals / Bioelectric Medicine
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

電療/生物電醫學全球市場預計2030年將達284億美元

電療/生物電醫學的全球市場預計 2023 年為 185 億美元，預計到 2030 年將達到 284 億美元，2023-2030 年分析期間複合年成長率為 6.3%。心臟心律調節器和 ICD 是本報告分析的細分市場之一，預計複合年成長率為 7.1%，到分析期結束時將達到 179 億美元。分析期間，人工電子耳領域的複合年成長率預計為 5.3%。

美國市場預估成長77億美元，中國複合年增率為7.2%

預計2023年美國電療/生物電醫學市場規模將達77億美元。中國作為世界第二大經濟體，預計2030年市場規模將達23億美元，2023-2030年分析期間複合年成長率為7.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.6% 和 6.1%。在歐洲，德國的複合年成長率預計約為 6.1%。

全球電子醫學/生物電子醫學市場 - 主要趨勢和促進因素總結

什麼是電療法以及它們將如何改變醫療保健？

電製藥，又稱生物電製藥，是醫學的前沿領域，專注於利用電脈衝調節人體神經系統並治療各種疾病。與使用化學物質觸發生物反應的傳統藥物不同，電治療藥物使用有針對性的電刺激來調節神經活動、影響器官功能並產生治療效果。這種方法可用於治療對常規藥物有抗藥性的疾病和病症，例如某些慢性疼痛症候群、心臟衰竭，甚至精神疾病。電療的原理在於連接大腦和各種器官的複雜神經網路。透過精確調整這些神經訊號，醫生的目標是直接糾正生物電源的異常。

技術如何推進電療應用？

微電子和生物技術的進步對於推進電療領域至關重要。神經映射方面的新進展以及能夠向體內目標區域發送精確電脈衝的小型植入式設備的開發極大地擴展了該技術的潛在應用。這些設備通常連接到穿戴式裝置或外部控制器，以便根據患者的特定需求即時客製化治療方案。這種高精度不僅提高了治療效果，還最大限度地減少了藥物等全身性治療常見的副作用。此外，正在進行的生物電訊號和神經介面研究預計將開發出更複雜的疾病治療方法，徹底改變慢性病的管理並減少對藥物干預的依賴。

電子藥物在目前治療中發揮什麼作用？

電子製藥目前應用於各種醫療環境，特別是疼痛、神經病變和心臟病的治療。例如，脊髓刺激設備可以顯著減輕藥物治療不足或不適當的患者的慢性疼痛。同樣，深層腦部刺激器在治療帕金森氏症症狀方面顯示出希望，可顯著改善患者的生活品質。在心臟病學中，心律調節器和植入式心臟整流去顫器(ICD) 可糾正異常心律並預防心臟衰竭和心臟猝死。電子藥物在治療多種疾病方面的多功能性提高了電子藥物將成為未來醫療實踐中的支柱的可能性，特別是隨著技術的進步和神經系統中新的​​治療標靶的發現。

是什麼推動了電療藥物市場的成長？

電療藥物市場的成長受到技術創新、全球人口老化和慢性病負擔增加等多種因素的推動。隨著生物醫學研究提供更複雜和小型化的設備，電子製藥的應用範圍將會擴大，使臨床醫生能夠以更大的功效解決更廣泛的病症。世界人口老化的變化正在增加適合電療的慢性疾病的盛行率，例如心血管疾病和神經系統疾病。此外，不斷上漲的醫療費用，特別是長期使用藥物，通常使電療藥物成為經濟有效的替代方案。消費者的行為也在改變，人們越來越傾向於副作用較少的無藥物治療。

受訪企業範例（共50家）

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP11726

Global Electroceuticals / Bioelectric Medicine Market to Reach US$28.4 Billion by 2030

The global market for Electroceuticals / Bioelectric Medicine estimated at US$18.5 Billion in the year 2023, is expected to reach US$28.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.9 Billion by the end of the analysis period. Growth in the Cochlear Implants segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Electroceuticals/Bioelectric Medicine Market - Key Trends & Drivers Summarized

What Are Electroceuticals and How Are They Transforming Medicine?

Electroceuticals, also known as bioelectric medicines, represent a cutting-edge field in medical science that focuses on using electrical impulses to modulate the body's nervous system to treat a variety of ailments. Unlike traditional pharmaceuticals that use chemicals to provoke a biological response, electroceuticals employ targeted electrical stimulation to modulate nerve activity, influencing organ function and offering therapeutic benefits. This approach can be used to treat diseases and conditions that have been resistant to conventional medicines, such as certain chronic pain syndromes, heart failure, and even mental health disorders. The principle behind electroceuticals lies in the intricate network of nerves that link the brain to different organs; by precisely adjusting these nerve signals, doctors aim to correct abnormalities directly at their bioelectrical source.

How Is Technology Advancing Electroceutical Applications?

The advancements in microelectronics and biotechnology have been pivotal in propelling the field of electroceuticals forward. Modern techniques in neural mapping and the development of miniature, implantable devices capable of delivering precise electrical impulses to targeted areas within the body have significantly broadened the potential applications of this technology. These devices are often connected to wearable or external controllers that allow for real-time adjustments in therapy, tailored to patient-specific needs. This level of precision not only enhances the effectiveness of treatment but also minimizes side effects commonly associated with more systemic treatments like drugs. Additionally, ongoing research in bioelectrical signaling and neural interfaces promises to unlock even more sophisticated methods of treating diseases, potentially revolutionizing the management of chronic conditions and reducing dependence on pharmacological interventions.

What Role Does Electroceuticals Play in Current Medical Treatments?

Currently, electroceuticals are being applied in a variety of medical contexts, most notably in the management of pain, neurological disorders, and cardiac issues. For example, spinal cord stimulators can significantly alleviate chronic pain in patients for whom pharmaceutical treatments are insufficient or inappropriate. Similarly, deep brain stimulators have shown promise in treating Parkinson’s disease symptoms, substantially improving life quality for affected individuals. In cardiology, devices like pacemakers and implantable cardioverter-defibrillators (ICDs) correct abnormal heart rhythms, crucially preventing heart failure and sudden cardiac death. The versatility of electroceuticals in treating such diverse conditions underscores their potential to be a mainstay in future medical practices, particularly as technologies improve and new therapeutic targets within the nervous system are discovered.

What Drives the Growth in the Electroceuticals Market?

The growth in the electroceuticals market is driven by several factors, including technological innovations, an aging global population, and an increasing burden of chronic diseases. As biomedical research delivers more sophisticated and miniaturized devices, the applicability of electroceuticals expands, allowing clinicians to address a broader range of conditions with greater efficacy. The demographic shift towards an older population worldwide leads to a higher prevalence of chronic diseases, such as cardiovascular disorders and neurological conditions, which are well-suited for electroceutical interventions. Furthermore, the rising cost of healthcare, particularly the long-term use of pharmaceuticals, makes electroceuticals a cost-effective alternative in many cases. Consumer behavior is also shifting; there is a growing preference for treatments that have fewer side effects and do not involve drug intake, which often aligns well with electroceutical solutions.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Electroceuticals / Bioelectric Medicine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction to Electroceuticals/Bioelectric Medicine
    • Using Electrical Stimulation in Nerves: Historical Perspective
    • Types of Electroceutical Devices
    • Major Applications of Electroceuticals/Bioelectric Medicine
    • Global Market Prospects & Outlook
    • Implantable Electroceutical Devices: The Leading Category
    • Cardiac Pacemakers & Implantable Cardioverter Defibrillators Segment Lead the Global Market
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • Global DBS Market Share Breakdown of Revenues by Leading Players: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Electroceutical/Biomedical Medicine Emerges to Overcome Drawbacks of Traditional Treatments
    • Faster Healing: A Key Benefit Fueling Growth in Electroceuticals Market
    • Ineffectiveness of Drug Therapy and Issues with Side Effects Present Opportunities for Electroceuticals Market
    • Disease-specific Electroceuticals to Drive Future Gains
    • Aging Global Population Raises Risk of Neurological & Cardiovascular Diseases, Fueling Market Outlook
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Prevalence of Cardiovascular Diseases and Need for Effective Treatments Supports Market Growth
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Cardiac Pacemaker: A Solution for Cardiac Arrythmias
    • Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
    • Technological Advancements to Transform Cardiac Pacemaker Devices Marketplace
    • Rising Incidence of Neurological Disorders and Need for Novel Therapies to Spur Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Bioelectronic Medicine Emerges as a Vital Therapy for Targeted Neuromodulation
    • Deep Brain Stimulators: Useful in Treatment of Neurodegenerative Diseases
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease in Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Developments in Vagal Nerve Stimulation (VNS) Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Biodegradable Devices For Nerve Recovery
    • Bioelectric Medicine: A Potential Treatment Approach for Crohn's Disease
    • Growing Prevalence of Hearing Loss Boosts Opportunities in the Cochlear Implants Market
    • Global Prevalence (%) by Severity of Hearing Loss
    • Vendors Focus on Innovations in Cochlear Implants
    • Developing Economies to Boost Long-term Prospects
    • Electroceutical Acupuncture: Emerging Pain Therapy
    • Neuropuncture - The Electroceutical Technology to Treat Pain & Injury
    • Bioelectronics Technology Fuels Advances in Next-Generation of Device Therapeutics
    • Market Benefits from the Significant Advantages of Bioelectronics
    • Overcoming the Challenges
    • Increasing Research Activity in Bioelectric Medicine Drives Market Opportunities
    • Market Poised to Benefit from the Development of New Bioelectronic Devices
    • Technological Advancements to Boost Growth Prospects
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiac Pacemakers & ICDs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cochlear Implants by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Clinics & ASCs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Electroceuticals / Bioelectric Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION